1. Goldman JM . Advances in CML. Clin Adv Hematol Oncol 2007; 5: 270–272.
2. Gómez-Almaguer D . Leucemias crónicas. In: Ruiz-Argüelles GJ (ed). Fundamentos de Hematología, 3rd edn. Editorial Médica Panamericana: México City, 2004, pp 246–260.
3. Ruiz-Argüelles GJ, López-Martínez B, Ramírez-Cabrera JM, Reyes-Nuñez V, Rodríguez-Cedeño H, Garcés-Eisele J . Molecular monitoring of the treatment of patients with BCR/ABL(+) chronic myelogenous leukemia. Rev Invest Clín Méx 2001; 53: 235–239.
4. Or R, Shapira MY, Resnick I, Amar A, Ackerstein A, Samuel S et al. Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. Blood 2003; 101: 441–445.
5. Ruiz-Argüelles GJ, Gómez-Almaguer D, López-Martínez B, Cantú-Rodríguez OG, Jaime-Pérez JC, González-Llano O . Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia. Haematologica 2002; 87: 894–896.